Benzbromarone is a drug that promotes uric acid excretion. For patients with indications, if the treatment is effective, the dose can be adjusted or discontinued on a trial basis, as appropriate. If the uric acid level cannot be controlled after stopping the drug, it should be continued. Therefore, the course of treatment of this drug should be determined according to the specific condition of the patient. Benzbromarone is generally used for hyperuricemia and gout from various causes. The dosage should be taken according to the instructions, usually once a day, after breakfast. It is contraindicated in cases of hypersensitivity to any of the ingredients of this drug, in pregnant women, in women at risk of pregnancy and in nursing mothers. It is important to pay attention to any adverse reactions, such as gastrointestinal discomfort, such as nausea, vomiting, feeling of fullness in the stomach and diarrhea, etc. If the situation is serious, the drug needs to be discontinued.